To account for enhanced susceptibility to infection among galactosemics, the acute effects of D-galactose on metabolic and functional activities of phagocytic cells in vitro were investigated. Human and guinea pig polymorphonuclear leukocytes (PMN) when incubated in medium containing 30 mM galactose displayed substantially less killing of Escherichia coli than when incubated in medium with 5 mM glucose. Impaired bactericidal activity was dependent upon galactose concentration but could be partially averted by supplementing the galactose-containing medium with 15 mM glucose. Phagocytic activities of guinea pig PMN and peritoneal macrophages were assayed by following ingestion of 32P-labeled E. coli and were also depressed by elevated galactose. Galactose was readily epimerized to glucose by resting PMN, and this conversion was stimulated by phagocytosis. Incubation of macrophages in the presence of galactose resulted in depletion of intracellular levels of adenosine 5'-triphosphate as well as other metabolites.
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Although bacterial infection (3, 22) and Escherichia coli septicemia (9, 17) are frequently reported among infants deficient in galactose-1-phosphate uridylyltransferase (EC 2.7.7.10), little is known about the functional integrity of the host defense mechanism during galactosemia. Among patients fed diets restricted in galactose content both cellular and humoral immune systems are believed to be functional (15) , but there is no pertinent information about the function of these systems in patients during galactose toxicity.
In the present communication, we suggest that increased susceptibility to infection may result from impaired phagocyte function during galactosemia. We demonstrate that elevated levels of galactose in vitro exert direct inhibitory effects upon the bactericidal activities of human and guinea pig polymorphonuclear leukocytes (PMN) and upon the phagocytic activities of guinea pig PMN and peritoneal macrophages. We also present data that indicate that the action of galactose on phagocytes is not primarily osmotic but may be attributable to changes in the intracellular levels of adenosine 5'-triphosphate (ATP) or other metabolites (results of preliminary studies were reported in Fed. Proc. 35:578, 1975 Human and guinea pig PMN were isolated from 10-ml samples of venous blood supplemented with 100 U of heparin (grade I, Sigma) per ml and 2-ml aliquots of 6% Dextran 250 (Pharmacia Fine Chemicals, Uppsala, Sweden) in phosphate-buffered saline, pH 7.4 . After 1 h of sedimentation at room temperature, leukocyte-rich supernatants were decanted and centrifuged at 250 x g for 5 min. Preparations were washed once with 0.87% NH4Cl to lyse remaining erythrocytes (2) , and leukocytes were suspended in Krebs-Ringer phosphate solution without calcium, pH 7.4, containing 10% autologous serum. Cell suspensions were gassed with a 95:5 mixture of 02-CO2, adjusted to the appropriate carbohydrate concentration and incubated for 1 h at 37 C prior to assaying for phagocytic or bactericidal activities. Amounts of D-glucose used as supplement were calculated after determining by gas chromatography the levels of carbohydrate contributed by sera (24) . Levels of glucose in sera varied from 4 to 6 mM, whereas levels of galactose were too low to be quantitated (less than 0.05 mM).
Guinea pig peritoneal macrophages were obtained 4 Cover slips containing peritoneal macrophages were removed at the same time intervals and at 180 min from culture media containing labeled E. coli (338 counts/min per 10" bacteria). Cover slips were rinsed three times with fresh media and transferred directly into scintillation vials with Bray's solution. All assays were performed in triplicate on cells pooled from three guinea pigs.
Killing of bacteria by human and guinea pig PMN was assayed by exposing 1.0-ml cell suspensions (1.3 x 107 PMN per ml) in sterile Erlenmeyer flasks to serum-treated bacteria and incubating at 37 C in a shaking water bath. Aliquots of 0.2 ml, removed immediately and at 120 min, were serially diluted with sterile distilled water and then mixed with sterile 4% Trypticase soy agar plus 0.5% glucose in petri dishes at 45 to 50 C. After incubating each dish at 37 C for 24 h, the number of viable bacteria per milliliter was determined by counting the number of colonies per dish and multiplying by the corresponding dilution factor. Each experiment was performed in triplicate using two plates per dilution with cells pooled from eight human donors or from at least three guinea pigs.
Oxidation of glucose and galactose. Tables 1  and 2 were dynamic, depending not only upon phagocytic and killing processes but also upon the rates of bacterial growth, it became necessary to establish whether galactose could be affecting the growth ofE. coli. For this purpose, growth curves were investigated under similar conditions but without PMN (Fig. 1) . High levels of galactose slightly impaired the growth of organisms, and this effect could not be prevented by increasing glucose levels. Thus, impairment of both PMN function and bacterial growth occurred in the presence of galactose.
It should be noted that the assay systems under study in Tables 1 and 2 were of similar design but differed with respect to the species of PMN and the type of serum employed. The number of bacteria added to each system also varied, and this probably accounts for observed discrepancies between the percentage of survival of E. coli in these tables at comparable carbohydrate levels (34. galactose with human and guinea pig PMN, respectively).
The extent to which galactose affects phagocytosis was determined by monitoring the uptake of 32P-labeled E. coli into guinea pig PMN and peritoneal macrophages. PMN incubated in medium containing 5 mM glucose displayed most phagocytosis, whereas cells incubated in similar media with 15 or 30 mM galactose displayed 87 or 76% of this activity, respectively (Fig. 2) . Effects of galactose on phagocytic activity were more pronounced when employing macrophages (Fig. 3) , where the same relative amounts of galactose decreased uptake to 67 and 47%, respectively. Although inhibition of phagocytosis contributes to the loss of bactericidal activity, the extent of this inhibition did not appear sufficient to account for all the impairment in killing capacity.
To further investigate losses of phagocytic and bactericidal function, the action of galactose upon metabolic processes associated with these functions was studied. right ordinate) by guinea pig PMN. PMN were incubated for 1 h at 37 C in media with 10% guinea pig sera and either 1.0 mM glucose (-) fold increase in glucose oxidation associated with phagocytosis was relatively unaffected. Evolution of '4CO2 from D-[6-14C]glucose by resting cells was 50-fold less than that evolved from D-[1-_4C]glucose and was impaired by galactose to a greater extent. Thus, either galactose inhibited glucose transport and/or oxidation or galactose was converted to glucose in sufficient amounts to lower its specific radioactivity.
The latter explanation appears correct (Table  3) . When resting or phagocytosing PMN were incubated for 3 h in media with 1.0 mM labeled glucose, the specific activities of residual glucose were essentially equal. Addition of 10 mM galactose to either medium, however, resulted in decreased specific activities. That phagocytosing cells converted more galactose to glucose than resting cells was suggested by these data and further verified by monitoring the evolution of 14CO2 from D-[1-_4C]galactose. Resting and phagocytosing cells incubated in media with 1.0 mM labeld galactose oxidized 0.59 and 1.70 nmol of galactose per h per 10" cells, respectively. These oxidation rates were approximately 10-fold less than those for glucose (data not shown) and appeared to be insufficient for normal bactericidal action of PMN when 30 mM galactose was provided (Table 1) .
Peritoneal macrophages cultured for 2 h in basal medium (Eagle) containing 5 mM glucose, 10% fetal calf serum, and 30 mM galactose showed significant decreases in intracellular ATP (P < 0.005) as well as elevations in levels of adenosine 5'-diphosphate and adenosine 5'-monophosphate (Table 4) . Cell viability was lowered under these conditions, and levels of all glycolytic intermediates, with the exception of pyruvate, were depressed. Our results, however, indicated that the action of galactose upon phagocytes was not related to osmolality, since the inhibitory effect of 30 mM galactose upon bactericidal activity could be averted by elevating glucose levels to 15 mM, and since morphological changes in PMN and macrophage associated with hypertonicity were not seen. Correlations between impaired activity and PMN viability, as well as between activity and cell clumping, were also not observed.
Since phagocytosis by PMN (19) , as well as by macrophage (8) , is known to depend largely upon energy supplied by glycolysis, suppression of this metabolic pathway may represent a primary action of galactose. Depressed levels of intracellular ATP and glycolytic intermediates were found in guinea pig peritoneal macrophages when incubated with elevated levels of galactose (Table 4) , and similar results were reported to occur in other tissues during galactose toxicity (5) . Suppression of glycolysis could arise from either of the following mechanisms: (i) an inhibition of glucose transport into the phagocyte, or (ii) an accumulation of galactose, or one of its metabolites, intracellularly with subsequent inhibition of one or more glycolytic enzymes. However, both galactose and galactose-l-phosphate are concentrated by leukocytes (7, 23) , and we have recently found that glucose, but not galactose, competitively inhibits the uptake of [3H(G)12-deoxyglucose into guinea pig PMN (unpublished data). Thus, competition for transport is an unlikely explanation for galactose action in these cells.
The rapid conversion of galactose to glucose in phagocytes (Table 3) can be accounted for by the combined action of the Leloir pathway enzymes and either a specific or nonspecific phosphatase. This pathway, while functioning to dilute the glucose label in our oxidation experiments, was stimulated by phagocytosis and may have contributed to depletion of intracellular ATP via a futile adenosine triphosphatase action. Similar cycles operating during galactose neurotoxicity have been previously reported (10) .
